<html><body><div style="width:400px;"><div class="tracker" data-tracker-id="twitter_1543257964592730112"><blockquote class="twitter-tweet"><p lang="en" dir="ltr">As part of guidance exists LITT -<br> <br>Emerging use to treat tumors, epilepsy, etc<br>High interest in the industry. Growing use.<br>Fairly early to the party<br><br>Chance to be a major % of sales and ⬆️ adoption for CLPT<br><br>But need to change standard of care (surgery, radiation, etc) = hard</p>&mdash; Guillermo (@NeuroStockDoc) <a href="https://twitter.com/NeuroStockDoc/status/1543257964592730112?ref_src=twsrc%5Etfw">July 2, 2022</a></blockquote>

</div></div></body><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></html>